Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $34.1900 (-1.95%) ($33.6000 - $34.1900) on Tue. Jun. 27, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.72% (three month average) | RSI | 57 | Latest Price | $34.1900(-1.95%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.3% a day on average for past five trading days. | Weekly Trend | HALO advances 1.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IFRA(32%) IBB(29%) IWO(29%) EWJ(28%) IWM(28%) | Factors Impacting HALO price | HALO will decline at least -1.36% in a week (0% probabilities). UUP(-23%) TBT(-20%) EDOC(-12%) INDA(-9%) IGOV(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.36% (StdDev 2.72%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $34.99(-2.29%) | 10 Day Moving Average | $34.68(-1.41%) | 20 Day Moving Average | $34.12(0.21%) | To recent high | -11.6% | To recent low | 13.4% | Market Cap | $4.673b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |